Literature DB >> 33368402

Cytotoxicity of zinc oxide nanoparticles to innate and adaptive human immune cells.

Agnieszka Czyżowska1, Anna Barbasz1.   

Abstract

Zinc oxide nanoparticles (ZnO-NPs) are widely used in almost every area of life. Therefore, exposure to them is unavoidable, which makes it necessary to assess their safety for humans. This paper aims to determine toxicity of ZnO-NPs of two diameters toward human immune cells responsible for: innate response (U-937 and HL-60) and acquired response (COLO-720L and HUT-78). Mitochondrial activity, membrane integrity, degree of cellular lipid oxidation, induction of inflammation, and activation of the apoptosis pathway were evaluated to determine differences in cellular response to the tested nanoparticles. ZnO-NPs with a diameter of 100 and 130 nm cause significant cell mortality at 25 and 12 mg/L, respectively. Mitochondrial damage leads to the activation of the caspase cascade and, consequently, to cell apoptosis. ZnO-NPs also cause peroxidation of membrane lipids. Due to the photocatalytic properties of ZnO-NPs, the effect of ultraviolet (UV) irradiation on the degree of their toxicity was also investigated. However, UV irradiation enhances the toxic effect of nanoparticles mainly by weakening the cell's defense capabilities. ZnO-NPs are cytotoxic to human immune system, and they may cause both long-term and short-term negative effects.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  UV irradiation; acquired immunity; cytotoxicity; innate immunity; zinc oxide nanoparticles

Mesh:

Substances:

Year:  2020        PMID: 33368402     DOI: 10.1002/jat.4133

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  1 in total

1.  Preparation of Cotton-Zinc Composites by Magnetron Sputtering Metallization and Evaluation of their Antimicrobial Properties and Cytotoxicity.

Authors:  Marcin Henryk Kudzin; Małgorzata Giełdowska; Paulina Król; Zuzanna Sobańska
Journal:  Materials (Basel)       Date:  2022-04-08       Impact factor: 3.748

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.